RIPK3


Summary: The product of this gene is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases, and contains a C-terminal domain unique from other RIP family members. The encoded protein is predominantly localized to the cytoplasm, and can undergo nucleocytoplasmic shuttling dependent on novel nuclear localization and export signals. It is a component of the tumor necrosis factor (TNF) receptor-I signaling complex, and can induce apoptosis and weakly activate the NF-kappaB transcription factor. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in RIPK3


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF TAS GO:0003713 transcription coactivator activity
MF IDA GO:0004672 protein kinase activity
MF IMP GO:0004672 protein kinase activity
MF ISS GO:0004674 protein serine/threonine kinase activity
MF TAS GO:0004674 protein serine/threonine kinase activity
MF IEA GO:0004704 NF-kappaB-inducing kinase activity
Showing 1 to 6 of 46 rows rows per page

Gene expression in normal tissue: RIPK3

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in RIPK3


Loading, please wait...
Database
Pathway ID
Pathway Des.
wikipathways WP231 TNF alpha Signaling Pathway
wikipathways WP2513 Nanoparticle triggered regulated necrosis
kegg hsa04217 Necroptosis - Homo sapiens (human)
kegg hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human)
kegg hsa04623 Cytosolic DNA-sensing pathway - Homo sapiens (human)
kegg hsa04668 TNF signaling pathway - Homo sapiens (human)
Showing 1 to 6 of 28 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD126 Tipifarnib 5
iGMDRD512 nutlin 3 3
iGMDRD772 BRD4770 3
iGMDRD560 MK-2206 2
Showing 1 to 4 of 20 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in RIPK3

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​